X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
RMG-03 shows beneficial effect in hyperinflammatory syndromes mediated by severe viral illnesses such as SARS-CoV-2. It has recently completed Phase 2 proof of concept study in COVID-19 patients.
Lead Product(s): RMG-03
Therapeutic Area: Infections and Infectious Diseases Product Name: RMG-03
Highest Development Status: Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 04, 2023
Details:
Pilocarpine is a muscarinic cholinergic agonist used on the eye to treat elevated intraocular pressure, various types of glaucoma, and to induce miosis. Also available orally to treat symptoms of dry mouth associated with Sjogren's syndrome and radiotherapy.
Lead Product(s): Pilocarpine Hydrochloride
Therapeutic Area: Dental and Oral Health Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 01, 2023
Details:
Gloperba is the first liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults and was made available in the United States in 2020.
Lead Product(s): Colchicine
Therapeutic Area: Rheumatology Product Name: Gloperba
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Scilex Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement June 14, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
